be_ixf;ym_202206 d_28; ct_50

Select Page

Latest Insights on AMZN

Great Stuff 7-17-2019 The Great Amazon Surveillance Sale
by Joseph Hargett July 17, 2019 Great Stuff
In years past, Amazon.com Inc.’s (Nasdaq: AMZN) Prime Day was an event to look forward to. I love online shopping — I never have to leave my house and deal with crowds and uppity cashiers. So, when the biggest online retailer has a massive two-day sale, it’s like Christmas in July. But this year was […]
Great Stuff 7-5-2019 Friday Four Play: Good Jobs = Bad News
by Joseph Hargett July 5, 2019 Great Stuff
That was quite the Fourth of July celebration, wasn’t it? The fireworks, the music … and stuff. Freedom was everywhere. It was awesome. I don’t know about you, but I’m beat this morning. Apparently, so is the market. But we’ll get to that in a minute. Next week, I’m going on vacation to celebrate my […]
Great Stuff 7-3-2019 Canopy Growth: “Don’t Bring Me Down, Bruce”
by Joseph Hargett July 3, 2019 Great Stuff
Canopy Growth Corp. (NYSE: CGC) has investors running, going out of their minds. Investors are thinking that they’re wasting their time. (Don’t bring me down, no, no, no, no, no.) If you haven’t heard, I’ll tell you once more before I get off the floor. Canopy Growth co-CEO Bruce Linton is out the door. In […]
Great Stuff 7-1-2019 The Trade War Truce Rally: AMD, Apple, Nvidia and Oil?
by Joseph Hargett July 1, 2019 Great Stuff
Today’s G-20 rally is no surprise. There was no way President Donald Trump was coming out of the G-20 meeting without a win — one way or another. And he certainly got a win. I’m not talking about the pause in the trade war — that was a given. It fits Trump’s M.O. to a […]
Great Stuff 06-25-2019 The Real Question for the $63 Billion AbbVie-Allergan Acquisition
by Joseph Hargett June 25, 2019 Great Stuff
I know my brain doesn’t work quite right. I wouldn’t be writing Great Stuff if it did. Today, I’m left with a burning question on AbbVie’s $63 billion cash and stock acquisition of Allergan. It’s not about the viability of the combined company. Both AbbVie Inc. (NYSE: ABBV) and Allergan PLC (NYSE: AGN) face serious […]

Newsletter Sign Up

Sponsored

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“I'm very Happy with your services. I hope you don't plan to retire any time soon! My retirement portfolio depends on your expert guidance. Keep up the great work! Thanks.”

- Randy

“Paul, your investment research has been a godsend. Our portfolio was just a tad over two million dollars. I paid my daughter's legal fees, my wife's medical expenses, helped my wife's stepmother with home repairs, loaned our son money for real estate. I also bought two used vehicles, one for our daughter and one for our eldest grandson. All told, these expenses added up to well over a quarter million dollars. I am happy to report that we have profits left over!”

- Taylor M.

“Paul, in September of 2017, I decided to go ‘all in’ on my stock positions and follow the portfolios in your services. My account value was $335,000. As of today, it totals 1.1 million dollars! Yes, that’s tripling my money in less than 3 years.”

- Suzie M.

Share This